1-4 of 4
Zeyad Kanaan
Close
Sort by
Journal Articles

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Mohamed Abdelfatah, MD, Ankit Anand, MD, Zeyad Kanaan, MD, Ali Al-Ameri, MD, Nairmeen Haller, PhD
Journal: Blood
Blood (2013) 122 (21): 4998.
https://doi.org/10.1182/blood.V122.21.4998.4998
Published: 2013
Journal Articles

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Ahmed Malkawi, MD, Ankit Anand, MD, Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD
Journal: Blood
Blood (2013) 122 (21): 5007.
https://doi.org/10.1182/blood.V122.21.5007.5007
Published: 2013
Journal Articles

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD
Journal: Blood
Blood (2012) 120 (21): 4796.
https://doi.org/10.1182/blood.V120.21.4796.4796
Published: 2012
Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD
Journal: Blood
Blood (2012) 120 (21): 4804.
https://doi.org/10.1182/blood.V120.21.4804.4804
Published: 2012